Literature DB >> 22664341

Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Vsevolod V Gurevich1, Eugenia V Gurevich.   

Abstract

The complexity of living systems exceeds everything else studied by natural sciences. Sophisticated networks of intimately intertwined signaling pathways coordinate cellular functions. Clear understanding how the integration of multiple inputs produces coherent behavior is one of the major challenges of cell biology. Integration via perfectly timed highly regulated protein-protein interactions and precise targeting of the "output" proteins to particular substrates is emerging as a common theme of signaling regulation. This often involves specialized scaffolding proteins, whose key function is to ensure that correct partners come together in an appropriate place at the right time. Defective or faulty signaling underlies many congenital and acquired human disorders. Several pioneering studies showed that ectopic expression of existing proteins or their elements can restore functions destroyed by mutations or normalize the signaling pushed out of balance by disease and/or current small molecule-based therapy. Several recent studies show that proteins with new functional modalities can be generated by mixing and matching existing domains, or via functional recalibration and fine-tuning of existing proteins by precisely targeted mutations. Using arrestins as an example, we describe how manipulation of individual functions yields signaling-biased proteins. Creative protein redesign generates novel tools valuable for unraveling the intricacies of cell biology. Engineered proteins with specific functional changes also have huge therapeutic potential in disorders associated with inherited or acquired signaling errors.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664341      PMCID: PMC3404258          DOI: 10.1016/j.cellsig.2012.05.012

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  130 in total

1.  Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats.

Authors:  Wen-Tao Deng; Astra Dinculescu; Qiuhong Li; Sanford L Boye; Jie Li; Marina S Gorbatyuk; Jijing Pang; Vince A Chiodo; Michael T Matthes; Douglas Yasumura; Li Liu; Fowzan S Alkuraya; Kang Zhang; Douglas Vollrath; Matthew M LaVail; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-06       Impact factor: 4.799

Review 2.  G protein-coupled time travel: evolutionary aspects of GPCR research.

Authors:  Holger Römpler; Claudia Stäubert; Doreen Thor; Angela Schulz; Michael Hofreiter; Torsten Schöneberg
Journal:  Mol Interv       Date:  2007-02

Review 3.  Beta-arrestins and cell signaling.

Authors:  Scott M DeWire; Seungkirl Ahn; Robert J Lefkowitz; Sudha K Shenoy
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

4.  Phosphorylated rhodopsin and heparin induce similar conformational changes in arrestin.

Authors:  K Palczewski; A Pulvermüller; J Buczyłko; K P Hofmann
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

5.  Binding of wild type and chimeric arrestins to the m2 muscarinic cholinergic receptor.

Authors:  V V Gurevich; R M Richardson; C M Kim; M M Hosey; J L Benovic
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

6.  Modular arrangement of proteins as inferred from analysis of homology.

Authors:  E L Sonnhammer; D Kahn
Journal:  Protein Sci       Date:  1994-03       Impact factor: 6.725

7.  Silent scaffolds: inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant.

Authors:  Maya Breitman; Seunghyi Kook; Luis E Gimenez; Britney N Lizama; Maria C Palazzo; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-04-20       Impact factor: 5.157

8.  The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase.

Authors:  W J Koch; J Inglese; W C Stone; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

9.  Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors.

Authors:  V V Gurevich; S B Dion; J J Onorato; J Ptasienski; C M Kim; R Sterne-Marr; M M Hosey; J L Benovic
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

10.  Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling.

Authors:  W J Koch; B E Hawes; J Inglese; L M Luttrell; R J Lefkowitz
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

View more
  19 in total

Review 1.  Extensive shape shifting underlies functional versatility of arrestins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Curr Opin Cell Biol       Date:  2013-11-16       Impact factor: 8.382

2.  Mutations in arrestin-3 differentially affect binding to neuropeptide Y receptor subtypes.

Authors:  Luis E Gimenez; Stefanie Babilon; Lizzy Wanka; Annette G Beck-Sickinger; Vsevolod V Gurevich
Journal:  Cell Signal       Date:  2014-03-29       Impact factor: 4.315

3.  Arrestins in host-pathogen interactions.

Authors:  Stefano Marullo; Mathieu Coureuil
Journal:  Handb Exp Pharmacol       Date:  2014

Review 4.  Beyond traditional pharmacology: new tools and approaches.

Authors:  E V Gurevich; V V Gurevich
Journal:  Br J Pharmacol       Date:  2015-06-10       Impact factor: 8.739

Review 5.  Plethora of functions packed into 45 kDa arrestins: biological implications and possible therapeutic strategies.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Mol Life Sci       Date:  2019-08-17       Impact factor: 9.261

6.  Engineering visual arrestin-1 with special functional characteristics.

Authors:  Sergey A Vishnivetskiy; Qiuyan Chen; Maria C Palazzo; Evan K Brooks; Christian Altenbach; Tina M Iverson; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

7.  Therapeutic potential of small molecules and engineered proteins.

Authors:  Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

8.  Arrestins in apoptosis.

Authors:  Seunghyi Kook; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Handb Exp Pharmacol       Date:  2014

9.  Critical role of the central 139-loop in stability and binding selectivity of arrestin-1.

Authors:  Sergey A Vishnivetskiy; Faiza Baameur; Kristen R Findley; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2013-03-08       Impact factor: 5.157

10.  A non-GPCR-binding partner interacts with a novel surface on β-arrestin1 to mediate GPCR signaling.

Authors:  Ya Zhuo; Vsevolod V Gurevich; Sergey A Vishnivetskiy; Candice S Klug; Adriano Marchese
Journal:  J Biol Chem       Date:  2020-08-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.